Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 0 | 0 | 0 | 21 | 0 |
| Gross Profit | N/A | N/A | N/A | 21 | 0 |
| Operating Expenses | 2,669 | 2,113 | 2,059 | 2,167 | 1,734 |
| Operating Income | -2,669 | -2,113 | -2,059 | -2,146 | -1,734 |
| Other Income | 9 | 19 | 24 | 27 | 7 |
| Pre-tax Income | -2,660 | -2,094 | -2,035 | -2,119 | -1,727 |
| Net Income Continuous | -2,660 | -2,094 | -2,035 | -2,119 | -1,727 |
| Net Income | $-2,660 | $-2,094 | $-2,035 | $-2,119 | $-1,727 |
| EPS Basic Total Ops | -483.00 | -489.48 | -499.21 | -616.99 | 3,884.17 |
| EPS Basic Continuous Ops | -481.29 | -489.75 | -499.75 | -617.16 | 3,896.22 |
| EPS Diluted Total Ops | -483.00 | -489.48 | -499.21 | -616.99 | 3,884.17 |
| EPS Diluted Continuous Ops | -481.29 | -489.75 | -499.75 | -617.16 | 3,896.22 |
| EBITDA(a) | $-2,653 | $-2,098 | $-2,041 | $-2,128 | $-1,714 |